124 related articles for article (PubMed ID: 2337405)
1. Immunohistochemical localization of filaggrin in benign and malignant lesions of the human oral mucosa.
Grosso M; Lentini M; Bellizi De Marco E; Petracca R; Leoncini P; Carrozza G
Basic Appl Histochem; 1990; 34(1):51-8. PubMed ID: 2337405
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of filaggrin in preneoplastic and neoplastic lesions of the human oral mucosa.
Itoiz ME; Conti CJ; Lanfranchi HE; Mamrack M; Klein-Szanto AJ
Am J Pathol; 1985 Jun; 119(3):456-61. PubMed ID: 4014435
[TBL] [Abstract][Full Text] [Related]
3. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
5. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
[TBL] [Abstract][Full Text] [Related]
6. Pathology of malignant and premalignant oral epithelial lesions.
Greer RO
Otolaryngol Clin North Am; 2006 Apr; 39(2):249-75, v. PubMed ID: 16580910
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
Girod SC; Kühnast T; Ulrich S; Krueger GR
In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cytokeratin proteins during tumour progression in oral mucosa.
Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
Epithelial Cell Biol; 1994; 3(2):61-9. PubMed ID: 7528604
[TBL] [Abstract][Full Text] [Related]
9. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
Klein-Szanto AJ; Barr RJ; Reiners JJ; Mamrack MD
Arch Pathol Lab Med; 1984 Nov; 108(11):888-90. PubMed ID: 6385922
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous PAGE, immunoblotting, and immunohistochemical analysis of differentiation associated keratins in lesions of the oral mucosa.
Itoiz ME; Larcher F; Lanfranchi HE; Diaz J; Klein-Szanto AJ; Conti CJ
Acta Odontol Latinoam; 1993; 7(2):13-22. PubMed ID: 11885243
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
13. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB
J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543
[TBL] [Abstract][Full Text] [Related]
14. The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Serpico R; Rubini C; Fioroni M; Fanali S; Piattelli A
Anticancer Res; 2000; 20(5A):2891-7. PubMed ID: 11062698
[TBL] [Abstract][Full Text] [Related]
15. Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions.
Feng CJ; Li HJ; Li JN; Lu YJ; Liao GQ
Anticancer Res; 2008; 28(6A):3763-9. PubMed ID: 19189662
[TBL] [Abstract][Full Text] [Related]
16. Expression of keratin 13, 14 and 19 in oral hyperplastic and dysplastic lesions from Sudanese and Swedish snuff-dippers: association with human papillomavirus infection.
Ibrahim SO; Warnakulasuriya KA; Idris AM; Hirsch JM; Johnson NW; Johannessen AC
Anticancer Res; 1998; 18(1B):635-45. PubMed ID: 9584046
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa.
Giannelli G; Milillo L; Marinosci F; Lo Muzio L; Serpico R; Antonaci S
J Biol Regul Homeost Agents; 2001; 15(4):375-80. PubMed ID: 11860227
[TBL] [Abstract][Full Text] [Related]
18. Are differences in filaggrin expression suitable for discriminating benign, premalignant and malignant skin lesions? An immunohistochemical study.
Vigneswaran N; Haneke E; Hornstein OP
Pathol Res Pract; 1989 Apr; 184(4):402-9. PubMed ID: 2726606
[TBL] [Abstract][Full Text] [Related]
19. Protein and mRNA expression of simple epithelial keratins in normal, dysplastic, and malignant oral epithelia.
Su L; Morgan PR; Lane EB
Am J Pathol; 1994 Dec; 145(6):1349-57. PubMed ID: 7527618
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of DARPP-32 in oral premalignant and malignant lesions.
Pimenta FJ; Horta MC; Vidigal PV; De Souza BR; De Marco L; Romano-Silva MA; Gomez RS
Anticancer Res; 2007; 27(4B):2339-43. PubMed ID: 17695523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
